Alaye siwaju sii ― Yoruba

Confluent and reticulated papillomatosis (CRP) , ti a tun pe ni iṣọn-aisan Gougerot-Carteaud, awọn abajade lati idagbasoke sẹẹli awọ ara ajeji. O ṣe afihan bi awọn aaye dudu ti ko ni irora ti o le dapọ si awọn abulẹ nla, nigbagbogbo han lori àyà oke ati ọrun ti awọn ọdọ ati awọn ọdọ. Aṣayan itọju akọkọ jẹ minocycline.
Confluent and reticulated papillomatosis (CRP), also known as Gougerot-Carteaud syndrome, is caused by disordered keratinization. It presents with asymptomatic hyperpigmented papules that can coalesce into plaques and are typically located on the upper trunk and neck of teens and young adults. First-line treatment is oral 'minocycline'.

CRP maa n han bi awọn aaye dudu ati awọn abulẹ laisi awọn aami aisan lori awọ ara ni ayika ọrun, awọn apa, àyà oke, ati ẹhin oke. Nigba miiran, o le tan soke si iwaju ati isalẹ si agbegbe agbegbe. Awọn egboogi bii minocycline ti di yiyan itọju ti o fẹ.
CRP typically presents as asymptomatic hyperpigmented papules and plaques with peripheral reticulation over the nape, axillae, upper chest, and upper back, occasionally with extension superior to the forehead and inferior to the pubic region. Antibiotics, such as 'minocycline', at anti-inflammatory doses have emerged as a preferred therapeutic option.